← Leaderboards
Christopher Davis Reiter
Genvec, Inc.
$546,430
Attributed
$546,430
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $311.4K · FY2008–09$500K$375K$250K$125K$0
'08
'09
Funding mix
By agency
NIH$546,430 · 1
By mechanism
R21$546,430 · 1
Top collaborators
No co-investigators on record.
Most similar at Genvec, Inc.
Same institution · by research overlap
- Lisa L Wei$1,941,075
- Joseph T Bruder$2,184,286
Others in their field
Top investigators on “Exudative Age-Related Macular Degeneration”
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Maureen G Maguire · University Of Pennsylvania$13,127,335
- Traci Clemons · The Emmes Company, Llc$12,237,012
- Keri, Hammel · The Emmes Company, Llc$11,064,901
- Rohit Varma · University Of Southern California$8,567,783
- Mary Elizabeth Ruth Hartnett · University Of North Carolina Chapel Hill$7,881,287
Research focus
Exudative Age-Related Macular DegenerationEye DiseasesAngiogenesisAdenovirus VectorAnimal ModelAffectBiologicalBlindnessAdultAngiogenic FactorChemotactic FactorsChoroidal NeovascularizationCleaved CellAntiangiogenesis TherapyDesignDeveloped CountriesDeveloping CountriesDiabeticDiabetic RetinopathyBlood VesselsEndothelial CellsEnzymesEquilibriumFamily